American Bio Medica Corp (ABMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 183 | 222 | 74 | 266 | 335 |
| Depreciation Amortization | 281 | 185 | 89 | 269 | 188 |
| Accounts receivable | -494 | -498 | -244 | 94 | -354 |
| Accounts payable and accrued liabilities | -413 | -717 | -611 | 621 | 230 |
| Other Working Capital | -607 | -884 | -770 | -766 | -699 |
| Other Operating Activity | 907 | 1,227 | 855 | -350 | 248 |
| Operating Cash Flow | $-143 | $-465 | $-607 | $134 | $-52 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -125 | -99 | -59 | -601 | -392 |
| Investing Cash Flow | $-125 | $-99 | $-59 | $-601 | $-392 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 78 | 176 | N/A | N/A | 132 |
| Debt Repayment | -57 | -38 | -17 | -61 | -44 |
| Common Stock Issued | 3 | 3 | 2 | 581 | 581 |
| Other Financing Activity | 25 | 25 | 25 | 0 | -99 |
| Financing Cash Flow | $49 | $166 | $10 | $520 | $570 |
| Beginning Cash Position | 995 | 995 | 995 | 942 | 942 |
| End Cash Position | 776 | 597 | 339 | 995 | 1,172 |
| Net Cash Flow | $-219 | $-398 | $-656 | $53 | $230 |
| Free Cash Flow | |||||
| Operating Cash Flow | -143 | -465 | -607 | 134 | -52 |
| Capital Expenditure | -125 | -99 | -59 | -601 | -392 |
| Free Cash Flow | -268 | -564 | -666 | -467 | -444 |